Dr.Reddy's Laboratories Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dr.Reddy's Laboratories Ltd with three other
companies in this sector in India:
Cadila Healthcare Ltd
sales of 98.38 billion Indian Rupees [US$1.48 billion]
of which 100%
was Pharmaceutical Products),
(136.78 billion Indian Rupees [US$2.05 billion]
Aurobindo Pharma Ltd
(138.96 billion Indian Rupees [US$2.08 billion]
of which 100%
Dr.Reddy's Laboratories Ltd reported sales of 154.71 billion Indian Rupees (US$2.32 billion)
March of 2016.
increase of 4.4%
versus 2015, when the company's sales were 148.19 billion Indian Rupees.
Sales at Dr.Reddy's Laboratories Ltd have increased during each of the previous five years
(and since 2011, sales have increased a total of 107%).
Sales of Proprietary Products saw an increase
that was more than double the company's growth rate: sales were up
162.5% in 2016, from
1.01 billion Indian Rupees to 2.66 billion Indian Rupees.
Dr.Reddy's Laboratories Ltd also saw significant increases in sales in
Generics (up 6.2% to 128.06 billion Indian Rupees)
Others (up 38.1% to 1.61 billion Indian Rupees)
Not all segments of Dr.Reddy's Laboratories Ltd experienced an increase in sales in 2016:
sales of Active Pharmaceutical Ingredients and In fell 12.1% to 22.38 billion Indian Rupees.